Astrocytes as a key structural and functional component in the development of mixed dementia
- 20 October 2026
- journal article
- review article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (9) , 7-14
Abstract
Mixed dementia, characterized by a combination of Alzheimer’s disease and cerebrovascular disease (CVD), is prevalent among the elderly population. Accumulated evidence suggests that CVD plays an active role in the neurodegenerative process, enhancing the amyloid and tau pathways and contributing to the progressive disintegration of the brain’s functional and structural networks. This review presents data indicating that astrocytes serve as a critical integrative component, linking the pathologies associated with beta-amyloid and tau protein, dysfunction of the neurovascular unit, blood-brain barrier disorders, and alterations in the glymphatic system in patients with mixed dementia. We discuss the homeostatic roles of astrocytes along with their reactive transformations, characterized by enhanced Ca2+ signaling, metabolic interactions, polarization of aquaporin-4 (AQP4), and various inflammatory phenotypes. Astrocytes emerge as key modulators of systemic brain activity organization and as a central link uniting the pathological processes in mixed dementia. Targeting astrocyte-mediated mechanisms may pave the way for novel therapeutic approaches to address beta-amyloid and tau-proteinopathies.Keywords
This publication has 84 references indexed in Scilit:
- Cognitive impairment and p‐tau217 are high in a vascular patient cohortAlzheimer's & Dementia, 2025
- SUR1‐TRPM4 Regulates Aquaporin‐4 Subcellular Localization by Astrocytic Endfeet Calcium Signals Following Status EpilepticusGlia, 2025
- Plasma biomarkers of amyloid, tau, astrogliosis, and axonal injury in a mixed memory clinic cohortAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2025
- Cerebral hypoperfusion reduces tau accumulationAnnals of Clinical and Translational Neurology, 2024
- Glial ‘omics in ischemia: Acute stroke and chronic cerebral small vessel diseaseGlia, 2024
- Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Cross‐sectional and longitudinal assessments of function in prodromal‐to‐mild Alzheimer's disease: A comparison of the ADCS‐ADL and A‐IADL‐Q scalesAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023
- Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathologyAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022
- Human and mouse cortical astrocytes differ in aquaporin-4 polarization toward microvesselsGlia, 2017
- Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging BrainsJAMA Neurology, 2017